Clinical Trial of Investigational Vaccine to Treat LDL Cholesterol Underway
An investigational vaccine designed to lower LDL cholesterol is part of a Phase 1 clinical trial of VXX-401 for the treatment of hypercholesterolemia being conducted by Cape Canaveral, FL-based Vaxxinity, Inc.
Source: dicardiology.com